Probiotics for overactive bladder treatment
Part of Kidney & urinary clinical trials.
This study tests whether a daily probiotic supplement (Lactobacillus) can help reduce overactive bladder symptoms. It compares the supplement to a placebo in a randomized trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with overactive bladder syndrome or mixed incontinence where overactive bladder symptoms are the main issue
- You are 18 years or older
- You do not have a nerve-related bladder problem (neurogenic bladder)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the bacteria and chemicals in your urine change when women receive treatment for overactive bladder. It may help researchers understand why some treatments work better for some people.
This trial tests whether taking a probiotic (a 'good bacteria' supplement) daily for 3 months can help reduce overactive bladder symptoms in people who also have anxiety. It may help improve both bladder control and feelings of anxiety.
This research study compares the bacteria in urine, around the genital area, and in stool between children with overactive bladder (frequent urgent need to urinate) and healthy children. The goal is to understand if differences in these bacteria might explain why some children develop overactive bladder.
This study compares three ways to help people with overactive bladder: learning about the condition, using biofeedback to train your pelvic muscles, and using nerve stimulation. It aims to find which approach works best to reduce urgent, frequent urination.
This study looks at adults with overactive bladder (OAB) to learn more about the condition. It aims to help doctors understand different types of OAB and improve treatment.
This study looks at the bacteria in the bladders of women with overactive bladder who are getting Botox injections. It aims to understand how these bacteria might affect treatment results.
Hear when a new Overactive Bladder Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.